Renee A. Nolan is an associate at Lowey Dannenberg. She focuses her practice on consumer protection antitrust litigation, primarily pharmaceutical overcharge matters for healthcare clients.
Generic Delay: Ms. Nolan represents the United Food and Commercial Workers Health and Welfare Fund of Northeastern Pennsylvania and a proposed class of end-payor plaintiffs as co-lead counsel in In re Ranbaxy Generic Drug Antitrust Litigation pending before Judge Nathaniel Gorton in the District of Massachusetts. The class of indirect purchasers alleges that generic drug maker Ranbaxy violated antitrust and consumer protection laws when it engaged in a decade-long scheme obtaining lucrative first-to-file Abbreviated New Drug Applications for several generic drugs. This would have given Ranbaxy 180 days of market exclusivity upon generic entry, but rampant GMP violations at their manufacturing facilities left them without the ability to manufacture the drugs. In doing so, Ranbaxy created a bottleneck in the generic market that prevented the plaintiffs from obtaining cheaper generic drugs resulting in overcharges to the end-payors.
Illegal Kickbacks and Sham Charities: Ms. Nolan represents Health Care Service Corporation (“HCSC”) in the Superior Court of California alleging RICO and antitrust violations against pharmaceutical company Mallinckrodt for its multi-faceted scheme to raise prices of the drug H.P. Acthar Gel over 2800%. The suit alleges Mallinckrodt utilized an illegal co-pay charity, kickbacks to physicians, off label promotion, and the acquisition of a competitor drug to keep the price of Acthar at supracompetitive levels at the cost of vulnerable multiple sclerosis patients and resulting in exorbitant overcharges for payors.
Adulterated Drugs: Ms. Nolan was part of a team that recovered overcharges for a large group of insurers alleging they were induced to pay billions of dollars for adulterated and falsely marketed drugs that came from a GlaxoSmithKline factory with long-term good manufacturing practice problems that the pharmaceutical company hid from the FDA and payors.
Prior to joining Lowey, Ms. Nolan was an associate at a prominent insurance defense firm in suburban Philadelphia, where she was responsible for all aspects of a large caseload of general liability matters from inception through arbitration or settlement. Her practice included medical malpractice litigation representing doctors, medical professionals, and healthcare institutions. In addition, she was responsible for consulting with experts to perform pre-suit analysis of potential medical malpractice claims for a large hospital chain.
Ms. Nolan graduated from Villanova School of Law in 2013, where she researched legal ethics and healthcare issues as a research assistant for a law clinic professor. During law school, Ms. Nolan was a judicial extern for the Honorable Susan Peikes Gantman of the Superior Court of Pennsylvania and a summer intern for the Honorable Thomas P. Rogers of the Court of Common Pleas.
Ms. Nolan received her undergraduate degree from the Honors Program of Villanova University in 2008 with a degree in Classical Studies.
Ms. Nolan is an active member of the Pennsylvania and Montgomery Bar Associations. Additionally, she regularly serves as an arbitrator on arbitration panels in the Montgomery County Court of Common Pleas.
B.A. Villanova University (2008), cum laude
J.D. Villanova University School of Law (2013)
Pennsylvania and the U.S. District Court for the Eastern District of Pennsylvania